Novel Non-Immunologic Agents for Relapsed and Refractory Multiple Myeloma: A Review Article

SIMPLE SUMMARY: Immunotherapy-based treatments have brought many new options in the treatment of multiple myeloma; still, the disease will inevitably relapse as it remains incurable. The development of non-immunologic drugs is therefore still needed, particularly for patients with advanced myeloma w...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobin, Arthur, Gruchet, Cécile, Guidez, Stéphanie, Gardeney, Hélène, Nsiala Makunza, Laly, Vonfeld, Mathilde, Lévy, Anthony, Cailly, Laura, Sabirou, Florence, Systchenko, Thomas, Moya, Niels, Leleu, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534104/
https://www.ncbi.nlm.nih.gov/pubmed/34680358
http://dx.doi.org/10.3390/cancers13205210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534104/
https://www.ncbi.nlm.nih.gov/pubmed/34680358
http://dx.doi.org/10.3390/cancers13205210

Ejemplares similares